CLINICAL_TRIALS
trial_result
· 2021-08-06
Clinical Trial Update: A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma [Phase 2]
Summary
Phase 2 trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Adenoid Cystic Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-08-06